Sample Posts from the ADHD dataset. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Top-level overview for ADHD classification study. by Ahmed Akib Jawad Karim (20427740)

“…Referring to LastBERT, a customized student BERT model, we significantly lowered model parameters from 110 million BERT base to 29 million-resulting in a model approximately 73.64% smaller. …”

Percentage survival of <i>Acinetobacter baumannii</i> infected <i>Galleria mellonella.</i> by Techit Thavorasak (13138440)

Related to Fig 3. by Mohammad Nafees Ansari (22232505)

“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX^OE (mean ± SEM, <i>n</i> = 5) than BT-474_VECT^OE tumors. …”

IFA did not affect LPS-induced inflammation response. by Tingting Wang (123983)

IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. by Tingting Wang (123983)

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)

IFA reduced the virulence of hypervirulent <i>K</i>. <i>pneumoniae</i> in <i>G</i>. <i>mellonella</i> larvae. by Tingting Wang (123983)

The effect of IFN-β and Vit D on the IL-1β expression. by Farzad Nasri (8941850)

“…In the co-treatment groups, a significant dose-dependent decrease was seen in the IL-1β expression <b>(C)</b>. …”

IFA reduced the capsular biosynthesis through altering bacterial metabolism. by Tingting Wang (123983)

IFA effectively reduced the production of <i>K</i>. <i>pneumoniae</i> capsule. by Tingting Wang (123983)

IFA disarmed capsule-mediated immune evasion. by Tingting Wang (123983)

IFA abrogated capsule-associated hypermucoviscosity phenotypes of hypervirulent <i>K</i>. <i>pneumoniae</i>. by Tingting Wang (123983)

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

IFA sensitized hypervirulent <i>K</i>. <i>pneumoniae</i> to complement-mediated killing by inhibiting capsule. by Tingting Wang (123983)

Validation of distinct contribution of capsule and hypercapsule-associated HMV in IFA-conferred protection against hvKP infection using a <i>ΔrmpD</i>-K7 mutant. by Tingting Wang (123983)

Uptake of the intervention (N = 49). by Stanley Carries (21172287)

“…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”

Baseline characteristics of sample by trial arm. by Stanley Carries (21172287)

“…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”

CweL trial design. by Stanley Carries (21172287)

“…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”

Participant Flow. by Stanley Carries (21172287)

“…We piloted the Caregiver Wellbeing intervention in the eThekwini municipality, KwaZulu-Natal, South Africa. …”